Aurobindo Pharma Q2 Results
- BSE: 524804
- NSE: AUROPHARMA
- ISIN: INE406A01037
- Sector: Major Drugs
BSE
1,236.35
12.70 (1.04%)
12.70 (1.04%)Volume10.45 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
1,241.7518.05 (1.48%)
18.05 (1.48%)Volume1.76 M
Updated: Mon 25 Nov, 2024 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹7,796.07 Cr.(3.03%)
- Operating Profit₹1,183.86 Cr.(-2.59%)
- Profit After Tax₹817.38 Cr.(-11.08%)
- Operating Margin15.19%(11.22%)
Note: Comparison is on YoY basis
Quarterly - Aurobindo Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,796.07 | 6,850.52 | -% | 7,219.42 | -% |
| Selling/ General/ Admin Expenses Total | 1,109.48 | 951.97 | -% | 954.97 | -% |
| Depreciation/ Amortization | 382.28 | 326.56 | -% | 417.50 | -% |
| Other Operating Expenses Total | 1,910.18 | 1,592.47 | -% | 1,624.48 | -% |
| Total Operating Expense | 6,612.21 | 6,095.46 | -% | 6,233.69 | -% |
| Operating Income | 1,183.86 | 755.06 | -% | 985.73 | -% |
| Net Income Before Taxes | 1,207.46 | 812.03 | -% | 1,075.64 | -% |
| Net Income | 817.38 | 570.75 | -% | 757.18 | -% |
| Diluted Normalized EPS | 14.00 | 10.58 | -% | 12.83 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST